August 13, 2019 10:04 am
Published by jonas
On August 27, CEO Martin Vidaeus from Redwood Pharma will present at BioStock Live (www.biostock.se) in Stockholm. The presentation will... View Article
August 5, 2019 10:50 am
Published by jonas
Redwood Pharma AB (publ) today announces that the last patient has now been included in the company’s ongoing Phase II... View Article
June 19, 2019 6:17 pm
Published by jonas
Earlier this week, Redwood Pharma published an update on the Phase II clinical trial of RP101 where the company has... View Article
June 18, 2019 8:07 am
Published by jonas
As of today approximately 80 patients have been recruited in Redwood Pharma’s Phase II trial of RP101, the company’s new... View Article
February 11, 2019 9:35 am
Published by jonas
Redwood Pharma will be attending BIO-Europe 2019 in Vienna, Mar. 25 – 27 to meet and continue discussions with potential... View Article
February 4, 2019 8:00 am
Published by jonas
Redwood Pharma AB (publ) today announces that the first patient has begun testing ofRP101 in a Phase II clinical trial.... View Article
January 7, 2019 9:07 pm
Published by jonas
Redwood Pharma has now also received approval from the German Federal Institute for Drugs and Medical Devices (BfArM) to initiate... View Article
December 14, 2018 8:00 am
Published by jonas
Redwood Pharma has now also received approval from the Austrian Federal Office for Safety in Health Care (BASG / AGES)... View Article
November 12, 2018 11:44 pm
Published by jonas
Redwood Pharma has received its first national approval from the Hungarian National Ministry of Pharmacy regarding the start of the... View Article
October 2, 2018 8:57 am
Published by jonas
The European Patent Office EPO has issued a prior notice of granting a new patent in the portfolio that Redwood... View Article